CISPLATIN - IMPACT OF A NEW ANTI-CANCER AGENT ON CURRENT THERAPEUTIC STRATEGIES
- 1 January 1981
- journal article
- research article
- Vol. 1 (4) , 199-204
Abstract
The role of cisplatin in current [human] cancer chemotherapy is illustrated. This new agent is increasingly utilized in 1st line regimens for a variety of tumor types, notably testicular, head and neck and bladder cancer. Large scale investigations are evaluating these regimens in combined modality approaches to early stages of these diseases.This publication has 19 references indexed in Scilit:
- Combination therapy of advanced head and neck cancer.Induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapyCancer, 1978
- Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary reportJAMA, 1977
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- ADRIAMYCIN-CYCLOPHOSPHAMIDE AND ADRIAMYCIN-CIS-DICHLORODIAMMINEPLATINUM(II) COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER1977
- CIS-DICHLORODIAMMINEPLATINUM (II) IN TREATMENT OF EPIDERMOID CARCINOMA OF HEAD AND NECK1977
- PHASE-1 STUDY OF HIGH-DOSE CIS-DICHLORODIAMMINEPLATINUM(II) WITH FORCED DIURESIS1977
- Combination chemotherapy with adriamycin andcis-diamminedichloroplatinum in patients with neoplastic diseasesCancer, 1976
- Combination Chemotherapy with cis-Diamminedichloroplatinum (II) and Bleomycin in Tumors of the Head and NeckOncology, 1975